Endovascular thrombectomy is beneficial for functional nonagenarians - a multicenter cohort analysis.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 21 06 2022
revised: 19 07 2022
accepted: 01 08 2022
pubmed: 3 9 2022
medline: 28 9 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

The use of endovascular thrombectomy (EVT) has dramatically increased in recent years. However, most existing studies used an upper age limit of 80 and data regarding the safety and efficacy of EVT among nonagenarians is still lacking. 767 consecutive patients undergoing EVT for large vessel occlusion (LVO) in three participating centers were recruited into a prospective ongoing database. Demographic, clinical and imaging characteristics were documented. Statistical analysis was done to evaluate EVT outcome among nonagenarians compared to younger patients. The current analysis included 41 (5.4%) patients older than 90 years. Compared to younger patients, nonagenarians were more often female (78% versus 50.3%, p ≤ 0.001), had worse baseline mRS scores (2 [0-3] versus 0 [0-2], p < 0.001), higher rates of hypertension and hyperlipidemia and a higher admission NIHSS (20 [14-23] versus 16 [11-20], p < 0.001). No differences were found between groups regarding the involved vessel, stroke etiology, time from symptoms to door or symptoms to EVT, successful recanalization rates and hemorrhagic transformation rates. Nonagenarians had worse mRS at 90 days (5 [3-6] versus 3 [2-5], p = 0.001), similar discharge NIHSS (5 [1-11] versus 4 [1-11], p = 0.78) and higher mortality rates (36.6% versus 15.8%, p < 0.001). All nonagenarians with baseline mRS 4 have died within 90 days. 36.4% of nonagenarian patients with baseline MRS of 3 or less had favorable outcome. This study demonstrates that nonagenarian stroke patients with baseline mRS of 3 or less benefit from EVT with no significant difference in the rate of favorable outcome compared to octogenarians.

Identifiants

pubmed: 36054973
pii: S1052-3057(22)00393-7
doi: 10.1016/j.jstrokecerebrovasdis.2022.106699
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

106699

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Ofer Rotschild (O)

Department of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64239, Israel.

Asaf Honig (A)

Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Hen Hallevi (H)

Department of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64239, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Anat Horev (A)

Department of Neurology, Soroka- University Medical Center, Beer-Sheva, Israel.

Estelle Seyman (E)

Department of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64239, Israel.

Einor Ben-Assayag (E)

Department of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64239, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Tali Jonas-Kimchi (T)

Department of Radiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Udi Sadeh (U)

Department of Radiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Jose Cohen (J)

Department of Neurosurgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Ronen R Leker (RR)

Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Jeremy Molad (J)

Department of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64239, Israel. Electronic address: jeremymolad@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH